Skip to content

7-day free trial with a card.

Plans
TheDesperateTrader
Compare

ABVX vs GSK

TheDesperateTrader.com· Side-by-side stock comparison

$ABVX vs $GSK head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.

$81.63
Price
$47.78
-2.6%
Day change
-1.7%
$7.34B
Market cap
$98.26B
—
P/E ratio
—
—
Dividend yield
3.78%
82.9M
Free float
2.00B
68.76%
Institutional
16.58%
984K
Avg volume
4.8M
1.2x
Rel. volume
0.5x
15% of 52w
52-week range
12% of 52w
126
Scanner alerts 30d
73
Pharmaceutical Preparations
Sector
Pharmaceutical Preparations

ABVX vs GSK: trend, levels and the market

One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.

$GSK leads 4 of 5
Performance
-27.1%
1 year
+3.5%
-36%
vs S&P 500
-5.3%
-28.4%
3 months
-8.5%
-12%
1 month
-4.1%
Trend
Downtrend
Trend
Downtrend
$92.10 below
50-day avg
$49.32 below
$111.98 below
200-day avg
$52.31 below
Key levels
$84.16 +3.1%
Resistance
$49.68 +4%
$88.43 +8.3%
Loading zone
$46.70 -2.3%
none nearby
Support
none nearby
$ABVX$81.63
$GSK$47.77
SupportLoading zoneResistancePrice
  • ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
  • ·Neither kept up with the market over the past year: ABVX -27.1% and GSK +3.5%, against the S&P 500 at +8.8%.

Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.

ABVX vs GSK: the quick read

  • ·GSK is the larger company by market cap ($98.26B vs $7.34B).
  • ·ABVX has been more active on our scanner (126 vs 73 alerts in 30 days).
  • ·ABVX has the smaller float (82.9M vs 2.00B), which tends to mean sharper, more volatile moves.
  • ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
  • ·Both stay busy on our scanner, 126 and 73 unusual-volume alerts over 30 days, so neither is the quiet one here.
  • ·They are not really peers by size: GSK is more than 13x the market cap of ABVX, so the same dollar of news moves ABVX far harder.
  • ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
  • ·GSK pays a dividend and ABVX does not, which usually means one is being held for income and the other for the move.

Objective differences only. Not investment advice.

Watching ABVX or GSK? Get each morning’s movers by email

Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Frequently asked questions

Everything you need to know comparing ABVX and GSK on TheDesperateTrader.

Is ABVX or GSK the better stock?
"Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($98.26B vs $7.34B). ABVX has been more active on our scanner (126 vs 73 alerts in 30 days). ABVX has the smaller float (82.9M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
What is the difference between ABVX and GSK?
The differences that matter: GSK is roughly 13x the size of the other by market cap ($7.34B vs $98.26B); they trade at very different share prices ($81.63 vs $47.77); ABVX sits at 15% of its 52-week range against 12% for GSK; only GSK pays a dividend; our scanner flagged ABVX 126 times in the last 30 days against 73 for GSK. Everything above is measured from the latest completed session and SEC filings.
Which of ABVX and GSK is more active right now?
Right now ABVX is at about 1.2x its normal volume and GSK is at about 0.5x, so ABVX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
Is ABVX or GSK in the stronger trend?
ABVX is below its 50-day average of $92.10 and below its 200-day average of $111.98; GSK is below its 50-day average of $49.32 and below its 200-day average of $52.31. GSK leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
Is this comparison data live?
Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.

Trading ABVX or GSK? Get real-time unusual-volume alerts the moment either one moves, free.

Sign up free
No card · 5 premium days

Same sector, similar size. These are the peers each one is usually weighed against.

Explore the market

Free, live market tools. No account required to look.

Site GuideEvery page explained, and how to trade with itTop Stocks TodaySix ranked stocks, live charts, why each oneRegularsThe names that keep coming back to the top of the scannerDue DiligenceDeep dives on one ticker, traced to SEC filings and the tapeSuper PortfolioEvery big holding from 13F filings and corporate stakesFree Stock ScannersEvery scanner in one placeCaught EarlyWhat our scanner flagged before it ranHow It WorksOur data, methodology & accuracyTrading CalculatorsPosition size, profit & average downTrading Taxes ExplainedWash sales, trader status and what you oweStock Market TodayWhat’s actually moving right nowLow Float MoversWho traded their whole float todayBetting AgainstWho the market is short, and which funds hold putsOur Call RecordEvery name we posted and what it did next, losers includedStocks to WatchTop 10 to watch next session, with reasonsTrending StocksWhat’s moving & being searched nowStock Sectors & ThemesAI, crypto, energy, banks & 40 moreBiggest Gainers TodayTop gainers & most activeWhy Stocks Are MovingToday’s movers + the catalyst behind eachInsider BuyingStocks insiders are buying (Form 4)Biggest Losers TodayTop decliners & worst performersPremarket MoversTop gainers & losers before the bellGap ScannerBiggest gap ups & downs. Did it fill?After Hours MoversTop gainers & losers after the closeMost Active StocksHighest dollar-volume names52-Week Highs & LowsStocks making new highs & lowsStock SplitsUpcoming & recent, and what happened afterOversold StocksLowest RSI, mean-reversion watchLow Float StocksSmallest floats, squeeze watchMost Volatile StocksBiggest daily range by ATR%Most Shorted StocksHighest short % of floatShort Squeeze StocksTop squeeze candidates by scorePenny StocksMost active under $5Stocks Under $1Most active sub-$1 namesStocks Under $10Most active under $10Overbought StocksHighest RSI, extended / pullback watchWeekly MoversBiggest gainers & losers this weekStock ScreenerScan by price, volume & RVOLThe Money MapMarket cap added or wiped, by sectorSector PerformanceBest & worst sectors todayStore ClosuresRetail & restaurant stocks under pressureEarnings CalendarWho reports before open & after closeEarnings Next WeekThe week ahead, biggest names by dayMoving After EarningsBiggest post-earnings gainers & losersEconomic CalendarFOMC, CPI, jobs & market-moving dataDividend CalendarEx-dates, yields & buy-by datesIPO CalendarRecent & upcoming stock listingsDaily RecapHow each session played outRVOL ScannerLive unusual-volume alertsHalt ScannerLive trading halts & resumesStock Halts TodayHalted stocks + reasons & resumesMost-Halted StocksRanked: which stocks halt most, 30dLive AlertsThe real-time scanner feedSmart MoneyInsider buys, 5% stakes & 13FReddit RadarTrending tickers & top postsGoogle Search RadarStocks America is Googling nowMarket CalendarEconomic, earnings & dividends in oneCrypto PricesLive Bitcoin, Ethereum & top coinsCurrency ConverterExchange rates: EUR, GBP, JPY & moreMortgage RatesCurrent 30-year & 15-year ratesAI StocksThe AI buildout: chips, cloud & softwareSemiconductor StocksChipmakers & equipment, and why they move